Cardiology

In a post hoc analysis of the SURPASS-CVOT randomized clinical trial, researchers found that tirzepatide was associated with fewer cardiorenal events than dulaglutide in high-risk type 2 diabetes.

In SOUL, oral semaglutide was associated with fewer composite heart failure events in patients with type 2 diabetes and baseline heart failure.

A large real-world cohort analysis presented at the American College of Cardiology’s Annual Scientific Session suggests catheter ablation may be associated with improved survival and reduced stroke risk...

A systematic review and meta-analysis presented at the 2026 American College of Cardiology Scientific Session evaluated whether tafamidis was associated with improved survival in patients aged 80 years and...

In a population-based Ontario analysis, COVID-19 vaccination was not associated with increased sudden death risk in healthy people aged 12 to 50.

New reports link SARS-CoV-2 and RSV to persistent cardiopulmonary risk and describe distinct postviral lung and brain changes in a mouse model.

A post-hoc analysis presented at the American College of Cariology’s Annual Scientific Session suggests that maintaining functional stability, measured by 6-minute walk distance, is associated with lower...

A meta-analysis of randomized controlled trials presented at the American College of Cardiology’s Annual Scientific Session suggests RNA therapeutics reduce mortality and cardiac failure risk in...

A prespecified analysis of the HELIOS-B trial evaluates how vutrisiran affects individual components of quality of life in transthyretin cardiomyopathy, offering clinically relevant insights for cardiology...

New guideline recommendations from the ACC/AHA and 9 partner organizations prioritize earlier treatment, refined atherosclerotic cardiovascular disease risk prediction, and broader use of lipid biomarkers...